Launched in March 2017, BigData@Heart is a five-year project of the Innovative Medicines Initiative (IMI), a EU public-private consortium consisting of patient networks, learned societies, SMEs, pharmaceutical companies and academia. The project has three main objectives: To deliver clinically relevant disease phenotypes underpinning research and innovation; To deliver scalable insights from real world evidence, clinical- and pharmaco-epidemiology; To deliver through advanced